344860 — Innogene Co Cashflow Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesSpeculativeMicro CapNeutral

Annual cashflow statement for Innogene Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Interim Report	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	—	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	790	2,258	1,339	1,396	945
Depreciation
Amortisation
Non-Cash Items	450	132	197	164	-131
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-676	-435	-1,175	460	-230
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	802	2,185	597	2,251	811
Capital Expenditures	-15.1	-4.81	-34.4	-47.8	-39.6
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	30.3	-1,500	-366	-10,023	-282
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	15.2	-1,505	-401	-10,071	-322
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-568	-83.7	-111	7,729	-533
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	249	597	84.6	-91.3	-44